|Videos|September 18, 2015
Which Medications Will Be Growth Drivers in the Industry in the Next Few Years?
Doug Long, vice president of industry relations at IMS Health, talks about which approved or pipeline drugs will be growth drivers in the industry during the next few years.
Advertisement
Doug Long, vice president of industry relations at IMS Health, talks about which approved or pipeline drugs will be growth drivers in the industry during the next few years.
This video was recorded at the 2015 NACDS Total Store Expo.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
Enlicitide Meaningfully Lowers LDL-C at 24 Weeks in Patients At Risk for ASCVD Events
3
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
4
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
5